<DOC>
	<DOCNO>NCT00237224</DOCNO>
	<brief_summary>To evaluate safety efficacy ( measure clinical tumor response ) letrozole daily dose , 2.5 mg postmenopausal patient primary ( untreated ) breast cancer .</brief_summary>
	<brief_title>Open Label Study Postmenopausal Women With ER /or PgR Positive Breast Cancer Treated With Letrozole</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Letrozole</mesh_term>
	<criteria>1 . Postmenopausal woman able comply protocol requirement primary invasive breast cancer , histologically confirm core needle biopsy , whose tumor estrogen ( ER ) / progesterone ( PgR ) positive , define core biopsy immunohistochemistry &gt; 10 % positive malignant epithelial cell . 2 . Clinical stage *T2 , T3 , T4a , b , c , N0 , 1 2 , M0 Clinical stage T2 tumor Investigators opinion would eligible breastconserving surgery . 3 . Post menopausal status define one following : No spontaneous menses least 1 year , woman &gt; 55 year . Spontaneous menses within past 1 year amenorrhoeic woman â‰¤ 55 year ( e.g . spontaneous secondary hysterectomy ) , postmenopausal gonadotrophin level ( LH FSH level &gt; 40 IU/L ) postmenopausal estradiol level ( &lt; 5 ng/dl ) accord definition `` postmenopausal range '' laboratory involve . Bilateral oophorectomy . ( Prior diagnosis breast cancer ) . 4 . Tumor measurable clinical examination , mammography ultrasound . 1 . Prior treatment letrozole tamoxifen . 2 . Uncontrolled endocrine disorder diabetes mellitus , confirm hypo hyperthyroidism , Cushing 's Syndrome , Addison 's disease ( treat untreated ) . 3 . Patients unstable , angina , uncontrolled cardiac disease ( e.g . Class III IV New York Heart association 's Functional Classification ) . 4 . Patients bilateral breast tumor 5 . Patients eligible breast conserving surgery 6 . Evidence inflammatory breast cancer distant metastasis . Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Breast Cancer , ER and/or PgR positive , Letrozole</keyword>
</DOC>